BIODESIX, INC. Gain (Loss) on Extinguishment of Debt
BIODESIX, INC. (BDSX) reported Gain (Loss) on Extinguishment of Debt of -$248.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-02-26
- BIODESIX, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- BIODESIX, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- BIODESIX, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-06-30 was -$248.00K.
- BIODESIX, INC. gain (loss) on extinguishment of debt for the quarter ending 2022-12-31 was -$3.98M.
- BIODESIX, INC. gain (loss) on extinguishment of debt for fiscal 2024 was -$248.00K.
- BIODESIX, INC. gain (loss) on extinguishment of debt for fiscal 2022 was -$6.98M, a 403.79% decline from fiscal 2021.
- BIODESIX, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $2.30M.
| Period end | Gain (Loss) on Extinguishment of Debt 1 month | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | -$248.00K derived: sum of 3 quarters · filed 2026-02-26 | -$248.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$248.00K derived: sum of 2 quarters · filed 2025-11-03 | -$248.00K 10-Q · filed 2025-11-03 | ||
| 2024-06-30 | -$248.00K 10-Q · filed 2025-08-07 | -$248.00K 10-Q · filed 2025-08-07 | |||
| 2022-12-31 | -$3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$4.03M derived: sum of 2 quarters · filed 2024-03-01 | -$6.98M derived: sum of 3 quarters · filed 2024-03-01 | -$6.98M 10-K · filed 2024-03-01 | |
| 2022-09-30 | -$52.00K 10-Q · filed 2023-11-07 | -$3.00M derived: sum of 2 quarters · filed 2023-11-07 | -$3.00M 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | -$2.95M 10-Q · filed 2023-08-07 | -$2.95M 10-Q · filed 2023-08-07 | |||
| 2022-04-30 | -$18.00K 10-Q · filed 2022-08-04 | ||||
| 2021-12-31 | -$97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $3.03M derived: sum of 2 quarters · filed 2023-03-06 | $3.03M derived: sum of 3 quarters · filed 2023-03-06 | $2.30M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $3.12M 10-Q · filed 2022-11-03 | $3.12M derived: sum of 2 quarters · filed 2022-11-03 | $2.40M 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$728.00K 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | -$728.00K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |